JANINE D'AMICO: Open Payments
NPI 1851840540 · COMMACK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,372 in 66 payments from 15 companies in 2025. Trend: 2023 $1,280 · 2024 $1,595 · 2025 $1,372
Food & beverage: $1,372
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 23 | $349 |
| Novo Nordisk Inc | 10 | $187 |
| Xeris Pharmaceuticals, Inc. | 8 | $177 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $129 |
| Madrigal Pharmaceuticals | 4 | $98 |
| Lilly USA, LLC | 3 | $93 |
| Dexcom, Inc. | 3 | $68 |
| KYOWA KIRIN, INC. | 2 | $55 |
| Corcept Therapeutics | 1 | $45 |
| Ascendis Pharma Endocrinology Inc | 2 | $44 |
Products named: MINIMED 780G, RECORLEV, JARDIANCE, Ozempic, REZDIFFRA, Dexcom G6 Transmitter, CRYSVITA, Wegovy.
Industry payments across NY — which companies pay providers there.
